ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,617,678 | +191.5% | 173,593 | +97.1% | 0.01% | +500.0% |
| Q2 2022 | $1,241,000 | -70.8% | 88,059 | -51.7% | 0.00% | -33.3% |
| Q4 2021 | $4,251,000 | +3048.9% | 182,133 | +2145.5% | 0.00% | – |
| Q3 2021 | $135,000 | -86.3% | 8,111 | -79.9% | 0.00% | -100.0% |
| Q2 2021 | $984,000 | -56.6% | 40,356 | -54.0% | 0.00% | -66.7% |
| Q1 2021 | $2,265,000 | -5.6% | 87,788 | +95.6% | 0.00% | -25.0% |
| Q4 2020 | $2,399,000 | -17.5% | 44,883 | -36.3% | 0.00% | -55.6% |
| Q3 2020 | $2,907,000 | +54.5% | 70,479 | +81.7% | 0.01% | 0.0% |
| Q2 2020 | $1,881,000 | -31.0% | 38,799 | -39.9% | 0.01% | -59.1% |
| Q1 2020 | $2,726,000 | -24.8% | 64,513 | -23.9% | 0.02% | -12.0% |
| Q4 2019 | $3,626,000 | -46.3% | 84,751 | -54.8% | 0.02% | -54.5% |
| Q3 2019 | $6,750,000 | +539.8% | 187,552 | +269.0% | 0.06% | +587.5% |
| Q3 2018 | $1,055,000 | +189.0% | 50,829 | +112.6% | 0.01% | +166.7% |
| Q2 2018 | $365,000 | -80.2% | 23,913 | -70.9% | 0.00% | -84.2% |
| Q1 2018 | $1,846,000 | -53.9% | 82,166 | -38.3% | 0.02% | -32.1% |
| Q4 2017 | $4,007,000 | -61.0% | 133,080 | -51.2% | 0.03% | -69.9% |
| Q3 2017 | $10,279,000 | +30.8% | 272,875 | -3.2% | 0.09% | +13.4% |
| Q2 2017 | $7,860,000 | +7.4% | 281,806 | +32.4% | 0.08% | -3.5% |
| Q1 2017 | $7,316,000 | +1544.0% | 212,796 | +1279.3% | 0.08% | +2025.0% |
| Q4 2016 | $445,000 | -92.4% | 15,428 | -95.2% | 0.00% | -97.2% |
| Q2 2013 | $5,853,000 | – | 322,468 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |